Physician viewpoint: Cheaper insulin could cost people’s lives

Efforts to lower insulin costs could stiff-arm future diabetes treatments more effective and less painful than insulin needle jabs, Johns Hopkins senior resident Michael Rose, MD, wrote for The Atlantic.